More donor livers could be used for transplantation thanks to exciting new development, NICE says
Procedure will extend the life of a donor liver by double the length of time compared to now
NICE guideline set to address variation in provision of services for adults with cerebral palsy
NICE has published its guideline on the care and support needs of adults with cerebral palsy.
New migraine drug not cost-effective NICE says in draft guidance
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in draft guidance published today.
Third biological treatment gives more choice for people with severe asthma
Another potentially life-changing treatment should be available to people with a severe form of asthma, NICE says.
Latest news headlines
-
Hundreds more children and adults eligible for cochlear implants on the NHS
Hundreds more people with severe to profound deafness are expected to be eligible for cochlear implants each year, due to updated NICE guidance.
04 January 2019
-
New and upgraded roads should prioritise pedestrians, cyclists and public transport over motorised vehicles
Physical inactivity is responsible for one in six deaths and is believed to cost the UK £7.4 billion each year, including £900 million to the NHS
04 January 2019
-
Non-invasive MRI scan for Prostate Cancer recommended by NICE
NICE has recommended the scan as a first-line investigation for people with suspected clinically localised prostate cancer.
-
NICE recommends a CAR T-cell therapy for adults with some types of non-Hodgkin lymphoma
NICE has published final draft guidance recommending a breakthrough cancer treatment, called CAR T-cell therapy, for adults with certain types of non-Hodgkin lymphoma.
07 December 2018
-
Innovative heart procedure will extend lives of patients with faulty heart valve
Up to 400 patients each year are set to benefit from the procedure being made available more widely
05 December 2018
-
Antibiotics should be restricted for COPD
Healthcare professionals should consider the risk of antimicrobial resistance when deciding whether antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).